Credit Suisse to price buffered return equity notes on stock basket

By Sarah Lizee

Olympia, Wash., May 28 – Credit Suisse AG, London Branch plans to price 0% buffered return equity securities due June 3, 2021 linked to an equally-weighted basket of eight stocks, according to a 424B2 filing with the Securities and Exchange Commission.

The underlying stocks are Novartis AG, Merck & Co., Inc., Sanofi, Boston Scientific Corp., Humana Inc., Zimmer Biomet Holdings, Inc., UnitedHealth Group Inc. and AstraZeneca plc.

If the final basket level is greater than the initial basket level, the payout at maturity will be par plus 1.5 times the basket return, capped at par plus 19.5%. If the basket declines by 10% or less, the payout will be par. Otherwise, investors will lose 1% for every 1% that the basket declines beyond 10%.

Credit Suisse Securities (USA) LLC is the underwriter.

The notes will price on May 30.

The Cusip number is 22552FFX5.

© 2015 Prospect News.
All content on this website is protected by copyright law in the U.S. and elsewhere. For the use of the person downloading only.
Redistribution and copying are prohibited by law without written permission in advance from Prospect News.
Redistribution or copying includes e-mailing, printing multiple copies or any other form of reproduction.